Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B

NCT01467427 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01467427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01467427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
May 16, 2012
Completion date
November 17, 2023
Enrollment
25 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia b